Copper homeostasis and copper-induced cell death: Novel targeting for intervention in the pathogenesis of vascular aging DOI Open Access
Zhuoying Chen, Yuanyuan Li, Xiangjie Liu

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 169, P. 115839 - 115839

Published: Nov. 16, 2023

Copper-induced cell death, also known as cuproptosis, is distinct from other types of death such apoptosis, necrosis, and ferroptosis. It can trigger the accumulation lethal reactive oxygen species, leading to onset progression aging. The significant increases in copper ion levels aging populations confirm a close relationship between homeostasis vascular On hand, closely related occurrence various cardiovascular diseases throughout process. However, specific causes are not clear, different living environments stress patterns lead individualized By exploring correlations copper-induced aging, we gain novel perspective on pathogenesis enhance prognosis atherosclerosis. This article aims provide comprehensive review impacts including their effects endothelial cells, smooth muscle oxidative stress, ferroptosis, intestinal flora, factors. Furthermore, intend discuss potential strategies involving cuproptosis new insights for copper-related

Language: Английский

Cell death mediated by nanotechnology via the cuproptosis pathway: A novel horizon for cancer therapy DOI Creative Commons

Chuang Wei,

Qinrui Fu

View, Journal Year: 2023, Volume and Issue: 4(3)

Published: March 27, 2023

Abstract Cuproptosis, the current form of regulated cell death characterized by copper overload, oligomerization lipoacylated proteins, and loss Fe–S cluster has been proposed to function closely with human diseases, including cancer. Since its first identification in 2022, many strategies have developed induce cuproptosis for cancer therapy, such as small‐molecule drugs nanomaterials. Although reviews related reported, they remain at a basic mechanism level, summary covering recent progress field nanotechnologies cuproptosis‐based therapy not yet presented. Therefore, it is time fill gap shed light on future directions application this promising tool fight against In minireview, we expounded action emphasized feasibility triggering therapy. The treatments based nanoparticle‐induced was then described. Finally, challenges development emerging are also discussed.

Language: Английский

Citations

33

Cu-related agents for cancer therapies DOI
Chunhui Wang, Xinda Yang, Chunyan Dong

et al.

Coordination Chemistry Reviews, Journal Year: 2023, Volume and Issue: 487, P. 215156 - 215156

Published: April 13, 2023

Language: Английский

Citations

29

Role of cuproptosis in understanding diseases DOI Open Access

Shihan Cao,

Qian Wang,

Zhenzhen Sun

et al.

Human Cell, Journal Year: 2023, Volume and Issue: 36(4), P. 1244 - 1252

Published: May 8, 2023

Language: Английский

Citations

26

Amplifying cancer treatment: advances in tumor immunotherapy and nanoparticle-based hyperthermia DOI Creative Commons
Yi Zhang, Zheng Li, Ying Huang

et al.

Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14

Published: Oct. 6, 2023

In the quest for cancer treatment modalities with greater effectiveness, combination of tumor immunotherapy and nanoparticle-based hyperthermia has emerged as a promising frontier. The present article provides comprehensive review recent advances cutting-edge research in this burgeoning field examines how these two strategies can be effectively integrated. Tumor immunotherapy, which harnesses immune system to recognize attack cells, shown considerable promise. Concurrently, hyperthermia, utilizes nanotechnology promote selective cell death by raising temperature an innovative therapeutic approach. While both have individually potential, may amplify anti-tumor responses, improved outcomes reduced side effects. Key studies illustrating synergistic effects approaches are highlighted, current challenges future prospects discussed. As we stand on precipice new era treatment, underscores importance continued collaboration bringing treatments from bench bedside.

Language: Английский

Citations

23

Copper homeostasis and copper-induced cell death: Novel targeting for intervention in the pathogenesis of vascular aging DOI Open Access
Zhuoying Chen, Yuanyuan Li, Xiangjie Liu

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 169, P. 115839 - 115839

Published: Nov. 16, 2023

Copper-induced cell death, also known as cuproptosis, is distinct from other types of death such apoptosis, necrosis, and ferroptosis. It can trigger the accumulation lethal reactive oxygen species, leading to onset progression aging. The significant increases in copper ion levels aging populations confirm a close relationship between homeostasis vascular On hand, closely related occurrence various cardiovascular diseases throughout process. However, specific causes are not clear, different living environments stress patterns lead individualized By exploring correlations copper-induced aging, we gain novel perspective on pathogenesis enhance prognosis atherosclerosis. This article aims provide comprehensive review impacts including their effects endothelial cells, smooth muscle oxidative stress, ferroptosis, intestinal flora, factors. Furthermore, intend discuss potential strategies involving cuproptosis new insights for copper-related

Language: Английский

Citations

23